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Summary
 
Binding sites for the nuclear factor (NF)-
 
k
 
B transcription factor have been identified within
control regions of many genes involved in inflammatory and immune responses. Such 
 
k
 
B sites
are often found adjacent to those of interferon (IFN)-
 
g
 
–inducible transcription factors, suggest-
ing a requirement for multiple signaling pathways for gene regulation. Using fibroblasts from
RelA (p65)-deficient mice generated by gene targeting, we have investigated the role of this
subunit of NF-
 
k
 
B in gene activation by microbial lipopolysaccharide, tumor necrosis factor 
 
a
 
,
and in possible synergism with the IFN-
 
g
 
–signaling pathway. Our results indicate not only that
RelA is required for activation of key genes involved in adaptive (acquired) immune responses,
including major histocompatibility complex class I, CD40, and the Fas death receptor, but also
that both NF-
 
k
 
B–inducing signals and IFN-
 
g
 
 are necessary for maximal activation. In contrast,
neutrophil-specific chemokine genes KC and MIP-2, which can function as nonspecific medi-
ators in innate immune responses, were strongly induced by RelA in the absence of IFN-
 
g
 
.
Our results show that RelA plays a critical role in activation of immune system genes in re-
sponse to nonspecific stimuli and demonstrate a novel proapoptotic function for this protein in
Fas-induced cell death.
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I
 
nnate immune responses are dependent on the presence
of receptors that are capable of recognizing highly con-
served features present on microorganisms (1, 2). Thus,
LPS present in cell walls of gram-negative bacteria is recog-
nized by cell surface receptors present on many different
types of cells, and viral products such as double-stranded
(ds)RNA molecules can activate intracellular kinases (1, 2).
As a result of interaction of host cells with these foreign
substances, defense mechanisms may be initiated to neutral-
ize the invading infectious agents. Such innate defense
mechanisms have been highly conserved. Thus, both plants
and animals possess such mechanisms and in some cases
may even use similar mediators (3, 4). In contrast, an adap-
tive immune response exists only in vertebrates and is de-
pendent on the presence of antigen receptors displayed on
specialized cells of the immune system. However, an effec-
tive adaptive response in vertebrates generally requires par-
ticipation of innate response mediators. Signals produced
by the innate immune system may provide information
about the origin or harmfulness of foreign substances and
thus determine the kind of adaptive response that is gener-
ated (1, 2).
Microbial LPS and viral dsRNA are potent inducers of
nuclear factor (NF)-
 
k
 
B transcription factors, which have
been implicated in regulation of host defense mechanisms
in diverse species ranging from insects to mammals (3). Al-
though NF-
 
k
 
B can be activated in response to both non-
specific and antigen-specific signals generated during an
immune response in vertebrates, only nonspecific signals
may be inducers of NF-
 
k
 
B proteins in insects (5, 6), which
lack an adaptive immune system. The possible involvement
of NF-
 
k
 
B factors in both innate and adaptive responses
suggests they may function as an important link between
these two systems. NF-
 
k
 
B proteins exist as dimers which
typically reside in an inactive form in the cytoplasm com-
plexed with the inhibitory I
 
k
 
B proteins (3, 7). Treatment
of cells with inducers of NF-
 
k
 
B results in phosphorylation
and degradation of I
 
k
 
B proteins, which allows free NF-
 
k
 
B
proteins to translocate to the nucleus and regulate the ex-
pression of target genes (7). Activation of NF-
 
k
 
B target
genes often occurs within minutes of receiving an inducing
signal, making this system optimally responsive to many
harmful stimuli, including invading microbes, DNA dam-
aging agents, and oxidative stress (3, 7). The predominant
dimeric form of NF-
 
k
 
B in most cells is a complex of a 50-
kd protein (p50) and a 65-kd protein called RelA or p65
(7). However, studies on mice deficient in p50 and RelA
have revealed distinct functions for these proteins (8, 9) and 
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have identified a requirement for RelA for embryonic sur-
vival (9, 10). Gene disruption of other members of the NF-
 
k
 
B
family, p52, c-Rel, and RelB, have indicated key roles for
these proteins in various tissues (11–14).
Among the best characterized endogenously produced
inducers of NF-
 
k
 
B in mammals are the proinflammatory
cytokines TNF-
 
a
 
 and IL-1 (3). These cytokines can be
produced by nonspecific mechanisms such as macrophage
activation after phagocytosis or exposure to microbial prod-
ucts such as LPS. In addition, interaction of macrophages
with the T cell–derived cytokine IFN-
 
g
 
 can also result in
production of TNF-
 
a
 
 and IL-1. Activation of NF-
 
k
 
B by
these cytokines may activate expression of genes involved
in regulation of an inflammatory response (3). Indeed, our
previous studies with RelA
 
2
 
/
 
2
 
 mice have shown that RelA
is required for the activation of GM-CSF and I
 
k
 
B genes in
fibroblasts treated with TNF-
 
a
 
 (9). Recent studies have
also shown that this subunit of NF-
 
k
 
B can inhibit TNF-
 
a
 
–induced cell death, an adaptation that may allow TNF-
 
a
 
–responsive cells to function without induction of cell
death (15). Such an antiapoptotic function of RelA is likely
the result of activation of genes that inhibit TNF-
 
a
 
–induced
cell death.
Many genes containing potential NF-
 
k
 
B binding ele-
ments have been identified (7). Interestingly, such genes
often contain binding sites for other transcription factors as
well, including AP-1, NF-IL6, and members of the IFN-
 
g
 
–activated factors, signal transducer and activator of tran-
scription (STAT)1 and IFN-regulatory factor (IRF)-1 (16).
Thus, transcription factor interactions within control re-
gions may be used for optimal regulation of gene expres-
sion, as demonstrated biochemically for the IFN-
 
b
 
 gene
(17). Of particular interest are synergistic interactions be-
tween TNF-
 
a
 
–inducible and IFN-
 
g
 
–inducible factors.
These two cytokines cooperate to activate many target
genes, and such cooperation is often manifested in func-
tional interactions between monocytes/macrophages (source
of TNF-
 
a
 
) and T lymphocytes (source of IFN-
 
g
 
) in in-
flammatory and immune responses.
Although NF-
 
k
 
B factors have been implicated in regula-
tion of many important genes, the relatively ubiquitous na-
ture of these proteins has precluded determination of spe-
cific contributions of different subunits in gene activation.
One approach to determine the function of individual sub-
units is gene targeting in embryonic stem cells. Using this
approach, we have now analyzed the role of the RelA sub-
unit in activation of genes containing 
 
k
 
B-like binding sites
in fibroblasts, cells that not only are important for produc-
tion of chemokines and cytokines but which also function
as target cells for cytotoxic T cells and in some cases as
APCs (18). We find that RelA activation by LPS or TNF-
 
a
 
and activation of the IFN-
 
g
 
 pathway are both required for
activation of key genes involved in adaptive immune re-
sponses. In contrast, RelA activation alone is sufficient for
potent activation of genes involved in innate responses.
Our results indicate a dual role for RelA in regulation of
genes involved in both kinds of immune responses and in
potentiating adaptive responses by nonspecific stimuli.
 
Materials and Methods
 
Cell Culture and Treatments.
 
Mouse embryonic fibroblasts (MEFs)
derived from RelA-deficient mice (9) were cultivated in DMEM
supplemented with 10% calf serum and antibiotics. MEFs were
stimulated in the presence of 10 ng/ml of TNF-
 
a
 
 (Genzyme), 10
ng/ml of IFN-
 
g
 
 (Genzyme), or 10 
 
m
 
g/ml of LPS (Sigma) for the
time periods indicated in the figure legends.
 
Antibodies.
 
mAb against Fas receptor (Jo2) and PE-conjugated
hamster Jo2 were purchased from PharMingen. Jo2 was used at
1 
 
m
 
g/ml for Fas-induced cell killing.
 
Northern Blot Analysis.
 
RNA was isolated from cells grown
under normal conditions (untreated cells) or stimulated for 6 h
with LPS and/or cytokines. Total RNA was extracted using the
TRIzol reagent (Molecular Research Center) as recommended by
the manufacturer. 10 
 
m
 
g of total RNA was size fractionated on
denaturing formaldehyde gels for 4–5 h and transferred overnight
to a nylon membrane. Different mRNAs were detected by hy-
bridization to specific 
 
32
 
P probes (reverse transcription PCR
products from mouse fibroblast cDNA) in the presence of salmon
sperm DNA (Sigma) for 1 h at 68
 
8
 
C. Final washes (twice for 15
min) were performed in 0.2% SSC, 0.1% SDS at 25
 
8
 
C. RNA
loading was controlled by normalization to a 
 
b
 
-actin probe. The
different mRNA levels were quantified by phosphorimaging.
 
Flow Cytometric Analysis.
 
Cells were treated with LPS and/or
cytokines, harvested, and stained with PE-conjugated hamster
anti–murine Fas mAb Jo2 for 30 min on ice. Cells were washed
twice, fixed in 4% paraformaldehyde, and analyzed using a Bec-
ton Dickinson flow cytometer.
 
Analysis of Fas-mediated Cell Death.
 
MEFs were cultured for
12 h in the presence or absence of LPS, TNF-
 
a
 
, and/or IFN-
 
g
 
.
After treatments, cells were washed with fresh medium and anti–
mouse Jo2 was added overnight at 1 
 
m
 
g/ml. Cells were collected
and counted in the presence of trypan blue. Data are expressed as
a percentage of viable cells in the untreated population.
 
Results and Discussion
 
The RelA Component of NF-
 
k
 
B Is Critically Required for Ac-
tivation of Key Genes Involved in Adaptive Immune Responses.
 
The gene encoding for the MHC class I H-2 molecule can
be activated by TNF-
 
a
 
 and IFN-
 
g
 
 (19). Although NF-
 
k
 
B
sites have been found within transcriptional control regions
of this gene (20, 21), the role of NF-
 
k
 
B proteins in its acti-
vation is not known. Furthermore, transcription factors
that do not belong to the NF-
 
k
 
B family have also been
shown to bind specifically to the MHC 
 
k
 
B site (22).
Therefore, we wished to determine whether RelA partici-
pates in activation of this gene. To this end, primary MEFs
derived from RelA
 
1
 
/
 
2
 
 or RelA
 
2
 
/
 
2
 
 mice were first treated
with TNF-
 
a
 
 or LPS. We have previously shown that LPS
is a potent inducer of NF-
 
k
 
B in MEFs, although the effect
of such treatment on gene induction was not determined
(23). Treatments were carried out for 6 h, since this time
period is sufficient for maximal activation of the genes we
have studied and does not result in significant death of
RelA
 
2
 
/
 
2
 
 MEFs by TNF-
 
a
 
. Northern blot analysis of RNA
obtained from TNF-
 
a
 
– or LPS-treated RelA
 
1
 
/
 
2
 
 MEFs
showed a moderate increase in H-2 expression (two- to
threefold). However, this increase was significantly potenti-
ated in the presence of IFN-
 
g
 
 (10.5-fold with TNF-
 
a
 
). In 
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contrast, no induction of expression was seen in the
RelA
 
2
 
/
 
2
 
 cells after TNF-
 
a
 
 or LPS treatment, whereas
IFN-
 
g
 
–mediated activation of H-2 expression (threefold)
was unaltered in these cells (Fig. 1). These results demon-
strate that RelA is required for activation of the H-2 gene
after TNF-
 
a
 
 or LPS and for potentiation of expression in
the presence of IFN-
 
g
 
.
MHC class I is critical for the initial interaction between
T lymphocytes and target cells. We next tested whether
other genes functionally important in interactions between
T lymphocytes and target cells or APCs are also under
RelA control. The CD40 gene can be inducibly expressed
on APCs and is important for activation of both T cells
which express the CD40 ligand and the APCs (24). Once
again, TNF-
 
a
 
 or LPS treatment increased expression of
CD40 mRNA in RelA
 
1
 
/
 
2
 
 MEFs, and the presence of
IFN-
 
g
 
 synergistically increased the amount of CD40
mRNA. In contrast, RelA
 
2
 
/
 
2
 
 MEFs showed virtually no
increase in the amount of CD40 mRNA in the presence of
TNF-
 
a
 
 or LPS alone or in combination with IFN-
 
g
 
 (Fig. 1).
Next we tested the effect of these inducers on expression
of the Fas death receptor. Coupling of Fas expressed on tar-
get cells with Fas ligand expressed on T cells generally re-
sults in apoptotic demise of the target cell (25). Fas expres-
sion is generally low in most cells, although certain cells
such as hepatocytes constitutively express high levels of Fas
(25). As shown in Fig. 1, Fas expression was dramatically
induced by TNF-
 
a
 
 plus IFN-
 
g
 
 or LPS plus IFN-
 
g
 
 (
 
z
 
10-
fold), but less strongly by these inducers alone (2–3-fold).
Importantly, RelA
 
2
 
/
 
2
 
 MEFs showed greatly diminished
induction of Fas mRNA (approximately twofold) under
the same conditions (Fig. 1). These results provide the first
direct proof for a role of NF-
 
k
 
B in regulation of the MHC
class I, CD40, and Fas death receptor genes, and suggest
that NF-
 
k
 
B may play a key role in activation of genes in-
 
volved in specific immune responses by nonspecific stimuli
such as LPS. Activation of NF-
 
kB by such stimuli may thus
allow synchronous expression of multiple genes that carry
out similar or complementary functions.
IFN-g–dependent and –independent Gene Activation by RelA.
IFN-g is a potent activator of macrophages, especially in
combination with LPS. Two genes critically involved in
macrophage function that can also be activated in fibro-
blasts are those encoding the inducible form of nitric oxide
synthase (iNOS) and the proinflammatory cytokine IL-6.
Therefore, we tested whether activation of these genes was
dependent on RelA. As above, both iNOS and IL-6 genes
were potently induced by the combined effects of LPS and
IFN-g in RelA1/2 MEFs (Fig. 2 A). Interestingly, activa-
tion of these genes was considerably less after TNF-a or
TNF-a and IFN-g treatment (Fig. 2 A). Induction was
again significantly reduced in RelA2/2 MEFs (Fig. 2 A),
demonstrating that RelA is specifically required for activa-
tion of these genes. Next we tested the potential involve-
ment of RelA in regulation of chemokine gene expression.
Chemokines produced at sites of inflammation, often by fi-
broblasts, play an important role in both initiation and po-
tentiation of an inflammatory response. Thus IFN-induc-
ible protein (IP)-10, a chemokine specific for macrophages
and T lymphocytes (26), was also synergistically induced by
Figure 1. The RelA subunit of NF-kB is required for activation of
genes involved in adaptive immune responses. RNA was isolated from
RelA1/2 and RelA2/2 MEFs after 6 h of different treatments as indicated.
10 mg of total RNA was hybridized to specific labeled probes for H-2,
CD40, Fas, and b-actin.
Figure 2. IFN-g–dependent and –independent gene activation by
RelA. Northern blot analysis was performed as described in the legend to
Fig. 1. (A) IFN-g–dependent gene activation by NF-kB. The blot was
hybridized to labeled probes for iNOS, IL-6, and IP-10. (B) IFN-g–inde-
pendent gene activation by NF-kB. The blot was hybridized to labeled
probes for KC and MIP-2.1002 RelA Regulates Multiple Immune-response Genes
LPS or TNF-a and IFN-g in RelA1/2 MEFs, and induc-
tion was reduced in RelA2/2 MEFs (Fig. 2 A). Taken to-
gether, our results demonstrate that the RelA component
of NF-kB is important for gene induction by LPS and
TNF-a alone and for synergistic activation in the presence
of IFN-g.
An inflammatory response can occur without the in-
volvement of antigen-specific lymphocytes, often provid-
ing the first line of defense against invading pathogens. Key
leukocytes involved in such “immediate” responses are
neutrophils, which are attracted to infected or inflamed
sites by chemokines. Two such neutrophil-specific che-
mokines, KC (27) and macrophage-inflammatory protein
(MIP)-2 (28), were found to be potently induced by LPS
in RelA1/2 MEFs (and to a lesser degree by TNF-a),
whereas induction was significantly reduced in RelA2/2
MEFs (Fig. 2 B). Importantly, and in contrast to the exam-
ples described above, IFN-g neither induced expression of
these chemokines nor potentiated expression by LPS or
TNF-a treatments, in both RelA1/2 and RelA2/2 MEFs.
These results indicate a potentially dual role for RelA in
target gene regulation. In the absence of specific immune
effectors such as IFN-g produced by T cells, RelA alone
can function as a potent inducer of innate response genes,
e.g., neutrophil chemokines. However, IFN-g is required
for optimal induction by RelA of genes involved in an
adaptive immune response.
Interestingly, significant differences in induction of spe-
cific genes in response to LPS or TNF-a and in synergy
with IFN-g were noticed. For example, although MHC
class I, CD40, and Fas were activated to a comparable ex-
tent by TNF-a or LPS, the induction of IP-10, KC, and
MIP-2 is dramatically more by LPS than by TNF-a. The
basis for such differences is presently unclear, but they indi-
cate that different NF-kB inducers may activate distinct
heterodimers of RelA-containing complexes, and kB sites
in different genes may preferentially bind different het-
erodimers. Induction of iNOS expression in macrophages
requires c-Rel (29), suggesting that both RelA and c-Rel
are important for activation of this gene.
Increased Resistance of RelA-deficient MEFs to Fas-induced
Cell Death. We next wished to determine the conse-
quence of RelA-dependent activation of Fas expression on
induction of cell death by this receptor. First, we deter-
mined whether the observed induction of Fas mRNA cor-
related with increased surface expression of this molecule
after LPS, IFN-g, or LPS plus IFN-g treatment of RelA1/2
or RelA2/2 MEFs. Only LPS was used as the NF-kB acti-
vator, since it results in potent induction of Fas mRNA in
RelA1/2 cells in the presence of IFN-g and is not cyto-
toxic to RelA2/2 cells. Combined treatment of RelA1/2
MEFs with LPS and IFN-g resulted in an z10-fold in-
crease in Fas surface expression, as measured by FACS®
analysis, whereas LPS and IFN-g treatments alone resulted
in less significant increases (Fig. 3 A). In contrast, Fas ex-
pression was increased only twofold in RelA2/2 cells after
LPS plus IFN-g treatment (Fig. 3 B). Thus, potent mRNA
induction of Fas results in increased cell surface expression
of Fas in RelA1/2 but not in RelA2/2 MEFs. We have also
found that IFN-g treatment is moderately cytostatic to
both RelA1/2 and RelA2/2 cells (see Fig. 4, A and B, be-
low); in RelA2/2 cells, some cytotoxicity through likely
production of TNF-a or TNF-b was also noticed after
LPS and IFN-g treatment.
We then tested whether cross-linking with the Fas-spe-
cific Jo2 antibody (30) resulted in death of RelA1/2 or
RelA2/2 fibroblasts. Significant cell death was observed in
RelA1/2 cells by trypan blue staining when Jo2 was
added after LPS or IFN-g treatment, and combined treat-
ment resulted in even greater killing (85% compared with
similar treatments without Jo2; Fig. 4 A). No cell death was
observed in the absence of LPS or IFN-g treatment. In
contrast, Fas-induced cell death was significantly reduced in
RelA2/2 cells after LPS or combined treatment with LPS
and IFN-g (5% compared with similar treatments without
Jo2; Fig. 4 B). Our results indicate that the level of Fas ex-
Figure 3. Cell surface expression of Fas in RelA1/2 (A) and RelA2/2
MEFs (B). Cells were grown for 12 h in the presence or absence of LPS,
IFN-g, or LPS and IFN-g, washed, and stained with PE-conjugated
hamster anti–murine Fas antibody for analysis of Fas cell surface expres-
sion. Unstained cells were used as negative controls.1003 Ouaaz et al. Brief Definitive Report
pression may be critical in determining whether a cell will
undergo apoptosis after ligand binding, and that the RelA
component of NF-kB is required for activation of Fas ex-
pression and thus for induction of cell death by this recep-
tor. Furthermore, activation of Fas expression appears to be
directly mediated by RelA, since consensus NF-kB bind-
ing sites have been found in the human Fas promoter (31)
and induction of Fas expression was found to be indepen-
dent of new protein synthesis (data not shown).
Previous studies have demonstrated an antiapoptotic
function for RelA in TNF-a and DNA damage–induced
cell death pathways (15, 32–34). However, the results pre-
sented here indicate that RelA is involved in regulation of
both proapoptotic and antiapoptotic genes. Recent studies
suggest that Fas expression may be responsible for tissue de-
struction in mouse autoimmune disease models for experi-
mental autoimmune encephalomyelitis (EAE) and insulin-
dependent diabetes (IDD) (35–38). Indeed, elevated Fas
expression has been found in b cells of the pancreas (36).
Our results indicate that Fas expression may be elevated by
cytokines such as IFN-g, TNF-a, TNF-b, and IL-1 pro-
duced by infiltrating T cells and macrophages. A role for
NF-kB in regulation of Fas expression suggests that inhibi-
tion of this transcription factor may have therapeutic po-
tential for the treatment of autoimmune diseases.
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